Cargando…
Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
BACKGROUND: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are common sexually transmitted infections (STIs) associated with adverse outcomes, yet most countries do not test and conduct syndromic management, which lacks sensitivity and specificity. Innovations allow for expanded STI testi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663512/ https://www.ncbi.nlm.nih.gov/pubmed/34310524 http://dx.doi.org/10.1097/OLQ.0000000000001517 |
_version_ | 1784613654294953984 |
---|---|
author | Wynn, Adriane Moucheraud, Corrina Martin, Natasha K. Morroni, Chelsea Ramogola-Masire, Doreen Klausner, Jeffrey D. Leibowitz, Arleen |
author_facet | Wynn, Adriane Moucheraud, Corrina Martin, Natasha K. Morroni, Chelsea Ramogola-Masire, Doreen Klausner, Jeffrey D. Leibowitz, Arleen |
author_sort | Wynn, Adriane |
collection | PubMed |
description | BACKGROUND: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are common sexually transmitted infections (STIs) associated with adverse outcomes, yet most countries do not test and conduct syndromic management, which lacks sensitivity and specificity. Innovations allow for expanded STI testing; however, cost is a barrier. METHODS: Using inputs from a pilot program in Botswana, we developed a model among a hypothetical population of 50,000 pregnant women to compare 1-year costs and outcomes associated with 3 antenatal STI testing strategies: (1) point-of-care, (2) centralized laboratory, and (3) a mixed approach (point of care at high-volume sites, and hubs elsewhere), and syndromic management. RESULTS: Syndromic management had the lowest delivery cost but was associated with the most infections at delivery, uninfected women treated, CT/NG-related low-birth-weight infants, disability-adjusted life years, and low birth weight hospitalization costs. Point-of-care CT/NG testing would treat and cure the most infections but had the highest delivery cost. Among the testing scenarios, the mixed scenario had the most favorable cost per woman treated and cured ($534/cure). Compared with syndromic management, the mixed approach resulted in a mean incremental cost-effectiveness ratio of $953 per disability-adjusted life years averted, which is cost-effective under World Health Organization's one-time per-capita gross domestic product willingness-to-pay threshold. CONCLUSIONS: As countries consider new technologies to strengthen health services, there is an opportunity to determine how to best deploy resources. Compared with point-of-care, centralized laboratory, and syndromic management, the mixed approach offered the lowest cost per infection averted and is cost-effective if policy makers' willingness to pay is informed by the World Health Organization's gross domestic product/capita threshold. |
format | Online Article Text |
id | pubmed-8663512 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-86635122021-12-15 Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana Wynn, Adriane Moucheraud, Corrina Martin, Natasha K. Morroni, Chelsea Ramogola-Masire, Doreen Klausner, Jeffrey D. Leibowitz, Arleen Sex Transm Dis Original Studies BACKGROUND: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) are common sexually transmitted infections (STIs) associated with adverse outcomes, yet most countries do not test and conduct syndromic management, which lacks sensitivity and specificity. Innovations allow for expanded STI testing; however, cost is a barrier. METHODS: Using inputs from a pilot program in Botswana, we developed a model among a hypothetical population of 50,000 pregnant women to compare 1-year costs and outcomes associated with 3 antenatal STI testing strategies: (1) point-of-care, (2) centralized laboratory, and (3) a mixed approach (point of care at high-volume sites, and hubs elsewhere), and syndromic management. RESULTS: Syndromic management had the lowest delivery cost but was associated with the most infections at delivery, uninfected women treated, CT/NG-related low-birth-weight infants, disability-adjusted life years, and low birth weight hospitalization costs. Point-of-care CT/NG testing would treat and cure the most infections but had the highest delivery cost. Among the testing scenarios, the mixed scenario had the most favorable cost per woman treated and cured ($534/cure). Compared with syndromic management, the mixed approach resulted in a mean incremental cost-effectiveness ratio of $953 per disability-adjusted life years averted, which is cost-effective under World Health Organization's one-time per-capita gross domestic product willingness-to-pay threshold. CONCLUSIONS: As countries consider new technologies to strengthen health services, there is an opportunity to determine how to best deploy resources. Compared with point-of-care, centralized laboratory, and syndromic management, the mixed approach offered the lowest cost per infection averted and is cost-effective if policy makers' willingness to pay is informed by the World Health Organization's gross domestic product/capita threshold. Lippincott Williams & Wilkins 2022-01 2021-08-30 /pmc/articles/PMC8663512/ /pubmed/34310524 http://dx.doi.org/10.1097/OLQ.0000000000001517 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Studies Wynn, Adriane Moucheraud, Corrina Martin, Natasha K. Morroni, Chelsea Ramogola-Masire, Doreen Klausner, Jeffrey D. Leibowitz, Arleen Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana |
title | Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana |
title_full | Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana |
title_fullStr | Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana |
title_full_unstemmed | Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana |
title_short | Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana |
title_sort | bridging the gap between pilot and scale-up: a model of antenatal testing for curable sexually transmitted infections from botswana |
topic | Original Studies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663512/ https://www.ncbi.nlm.nih.gov/pubmed/34310524 http://dx.doi.org/10.1097/OLQ.0000000000001517 |
work_keys_str_mv | AT wynnadriane bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana AT moucheraudcorrina bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana AT martinnatashak bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana AT morronichelsea bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana AT ramogolamasiredoreen bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana AT klausnerjeffreyd bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana AT leibowitzarleen bridgingthegapbetweenpilotandscaleupamodelofantenataltestingforcurablesexuallytransmittedinfectionsfrombotswana |